Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice
- PMID: 19124175
- PMCID: PMC2996241
- DOI: 10.1016/j.neurobiolaging.2008.11.006
Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice
Abstract
Senile plaques are a major pathological hallmark of Alzheimer's disease (AD). Compelling evidence suggests that senile plaques lead to structural alterations of neuronal processes and that local toxicity may be mediated by increased oxidative stress. Anti-oxidant therapy can alleviate the neuronal abnormalities in APP mice, but the time-course of this beneficial effect is unknown. We used multiphoton microscopy to assess in vivo the characteristics of antioxidant treatment on senile plaques and neurites in AD model mice (APPswe/PS1dE9). We observed that α-phenyl-N-tert-butyl nitrone (PBN), Ginkgo biloba extract (EGb 761) and Trolox had no effect on the size of existing senile plaques. However, all anti-oxidants had a straightening effect on curved neurites. This effect was detected as soon as 4 days after commencing the treatment, and was maintained after 1 month of daily treatment, with no further increase in the effect. The straightening of neurites persisted 15 days after stopping the treatment. These data indicate that neuronal plasticity is fast and still active in adult animals, and suggest that amelioration of the neuritic distortions associated with senile plaques with antioxidants is both rapid and long lasting.
Copyright © 2008 Elsevier Inc. All rights reserved.
Figures




Similar articles
-
Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model.J Neuropathol Exp Neurol. 2006 Nov;65(11):1082-9. doi: 10.1097/01.jnen.0000240468.12543.af. J Neuropathol Exp Neurol. 2006. PMID: 17086105
-
The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.Neuroscience. 2013 Jan 3;228:294-300. doi: 10.1016/j.neuroscience.2012.10.045. Epub 2012 Oct 26. Neuroscience. 2013. PMID: 23103794
-
Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.Int J Mol Sci. 2021 Jan 30;22(3):1378. doi: 10.3390/ijms22031378. Int J Mol Sci. 2021. PMID: 33573114 Free PMC article.
-
Alzheimer's disease and amyloid: culprit or coincidence?Int Rev Neurobiol. 2012;102:277-316. doi: 10.1016/B978-0-12-386986-9.00011-9. Int Rev Neurobiol. 2012. PMID: 22748834 Review.
-
Antioxidant therapy in Alzheimer's disease: theory and practice.Mini Rev Med Chem. 2008 Nov;8(13):1395-406. doi: 10.2174/138955708786369582. Mini Rev Med Chem. 2008. PMID: 18991755 Free PMC article. Review.
Cited by
-
Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice.J Neuropathol Exp Neurol. 2013 Apr;72(4):272-85. doi: 10.1097/NEN.0b013e318288a8dd. J Neuropathol Exp Neurol. 2013. PMID: 23481704 Free PMC article.
-
Utilization of APPswe/PS1dE9 Transgenic Mice in Research of Alzheimer's Disease: Focus on Gene Therapy and Cell-Based Therapy Applications.Int J Alzheimers Dis. 2011;2011:517160. doi: 10.4061/2011/517160. Epub 2011 Oct 30. Int J Alzheimers Dis. 2011. PMID: 22114743 Free PMC article.
-
Antioxidant therapies for Alzheimer's disease.Oxid Med Cell Longev. 2012;2012:472932. doi: 10.1155/2012/472932. Epub 2012 Jul 25. Oxid Med Cell Longev. 2012. PMID: 22888398 Free PMC article. Review.
-
Pharmacologic treatment with OKN-007 reduces alpha-motor neuron loss in spinal cord of aging mice.Geroscience. 2022 Feb;44(1):67-81. doi: 10.1007/s11357-021-00506-y. Epub 2022 Jan 4. Geroscience. 2022. PMID: 34984634 Free PMC article.
-
Action Mechanisms of Curcumin in Alzheimer's Disease and Its Brain Targeted Delivery.Materials (Basel). 2021 Jun 16;14(12):3332. doi: 10.3390/ma14123332. Materials (Basel). 2021. PMID: 34208692 Free PMC article. Review.
References
-
- Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. Postgrad Med Spec No. 2005:6–22. - PubMed
-
- Armstrong RA. Plaques and tangles and the pathogenesis of Alzheimer's disease. Folia Neuropathol. 2006;44:1–11. - PubMed
-
- Behl C, Moosmann B. Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic Biol Med. 2002;33:182–191. - PubMed
-
- Birks J, Grimley EV, Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2002:CD003120. - PubMed
-
- Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, Lewis J, Hutton M, Tolnay M, Jucker M. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol. 2007;171:2012–2020. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases